Genmab A/S (GNMSF) EBT Margin (2018 - 2026)
Genmab A's (GNMSF) quarterly EBT Margin came in at 11.83% in Q1 2026, down 4596.0% YoY from 0.26% in Q1 2025, and down 127.41% on a QoQ basis from 43.16% in Q3 2025.
Genmab A/S (GNMSF) EBT Margin (2018 - 2026) Analysis & Trends
Genmab A (GNMSF) has 5 years of EBT Margin data on file, last reported at 11.83% in Q1 2026.
- Quarterly EBT Margin fell 4596.0% year-over-year to 11.83% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 33.05% (down 489.0% YoY) and the FY2025 annual result came in at 32.37%, down 1012.0% from the prior year.
- EBT Margin eased to 11.83% in Q1 2026, from 43.16% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 43.16% in Q3 2025 to a low of 11.83% in Q1 2026.
- A 3-year average of 32.07% and a median of 40.23% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2025 — EBT Margin soared 636 bps — and 2026, when it slumped 4596 bps.
- Tracing GNMSF's EBT Margin over 3 years: stood at 36.81% in 2024, then climbed by 17 bps to 43.16% in 2025, then tumbled by 127 bps to 11.83% in 2026.
- The last three EBT Margin figures came in at 11.83% (Q1 2026), 43.16% (Q3 2025), and 40.67% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.54% |
| Mar 31, 2026 | -11.83% |
| Sep 30, 2025 | 43.16% |
| Jun 30, 2025 | 40.67% |
| Mar 31, 2025 | 34.13% |
| Sep 30, 2024 | 36.81% |
| Jun 30, 2024 | 40.23% |
| Mar 31, 2024 | 41.29% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 67,248,452,652,513.27% |
| Dec 31, 2018 | 38.52% |